Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Scully

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of Oncology Practice|June 12, 2016
Cancer and Thrombotic MicroangiopathyMarie Scully
Haematologica|November 2, 2020
Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activityMarie Scully
Expert Review of Clinical Pharmacology|March 5, 2019
How an engineered therapy could replace the need for potentially harmful plasma infusionsMarie Scully
Seminars in Thrombosis and Hemostasis|September 21, 2016
Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in PregnancyMarie Scully
Blood|June 24, 2021
Congenital TTP: next stop, acuity and therapyMarie Scully
Blood|July 17, 2020
TTP: an open and shut (closed) caseMarie Scully
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 12, 2014
Trends in the diagnosis and management of TTP: European perspectiveMarie Scully
Blood Reviews|December 8, 2009
Inhibitory anti-ADAMTS 13 antibodies: measurement and clinical applicationMarie Scully
Hematology. American Society of Hematology. Education Program|December 10, 2017
Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathyMarie Scully
British Journal of Haematology|January 20, 2023
A 'needle in a haystack': Drug-induced thrombotic thrombocytopenic purpura-Association or causality?Marie Scully
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of Oncology Practice|June 12, 2016
Cancer and Thrombotic MicroangiopathyMarie Scully
Haematologica|November 2, 2020
Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activityMarie Scully
Expert Review of Clinical Pharmacology|March 5, 2019
How an engineered therapy could replace the need for potentially harmful plasma infusionsMarie Scully
Seminars in Thrombosis and Hemostasis|September 21, 2016
Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in PregnancyMarie Scully
Blood|June 24, 2021
Congenital TTP: next stop, acuity and therapyMarie Scully
Blood|July 17, 2020
TTP: an open and shut (closed) caseMarie Scully
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 12, 2014
Trends in the diagnosis and management of TTP: European perspectiveMarie Scully
Blood Reviews|December 8, 2009
Inhibitory anti-ADAMTS 13 antibodies: measurement and clinical applicationMarie Scully
Hematology. American Society of Hematology. Education Program|December 10, 2017
Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathyMarie Scully
British Journal of Haematology|January 20, 2023
A 'needle in a haystack': Drug-induced thrombotic thrombocytopenic purpura-Association or causality?Marie Scully
Pageof 16